ReviewJournal of the advanced practitioner in oncology2025

Understanding the Role and Clinical Management of Bridging Therapy During CAR T-Cell Therapy for Relapsed or Refractory Multiple Myeloma.

Yi L Hwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.